Xiaoyi Zhao

1.1k total citations
30 papers, 832 citations indexed

About

Xiaoyi Zhao is a scholar working on Rheumatology, Molecular Biology and Cancer Research. According to data from OpenAlex, Xiaoyi Zhao has authored 30 papers receiving a total of 832 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Rheumatology, 11 papers in Molecular Biology and 9 papers in Cancer Research. Recurrent topics in Xiaoyi Zhao's work include Osteoarthritis Treatment and Mechanisms (13 papers), Orthopaedic implants and arthroplasty (6 papers) and MicroRNA in disease regulation (6 papers). Xiaoyi Zhao is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (13 papers), Orthopaedic implants and arthroplasty (6 papers) and MicroRNA in disease regulation (6 papers). Xiaoyi Zhao collaborates with scholars based in China, Germany and United States. Xiaoyi Zhao's co-authors include Wei‐Ming Liao, Ziji Zhang, Zhiqi Zhang, Shu Hu, Yan Kang, Peihui Wu, Guping Mao, Xingzhao Wen, Minghui Gu and Fangang Meng and has published in prestigious journals such as Biomaterials, Advanced Functional Materials and FEBS Letters.

In The Last Decade

Xiaoyi Zhao

28 papers receiving 829 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoyi Zhao China 16 444 344 301 159 99 30 832
Leilei Zhong China 17 373 0.8× 409 1.2× 145 0.5× 106 0.7× 61 0.6× 36 875
Takuya Niimoto Japan 11 434 1.0× 299 0.9× 484 1.6× 140 0.9× 98 1.0× 14 822
David Guérit France 10 333 0.8× 221 0.6× 231 0.8× 81 0.5× 57 0.6× 16 667
Elena Kozhemyakina United States 10 574 1.3× 543 1.6× 234 0.8× 135 0.8× 47 0.5× 13 1.1k
Stéphane Boeuf Germany 17 383 0.9× 372 1.1× 290 1.0× 138 0.9× 33 0.3× 20 958
Shuizhong Cen China 19 579 1.3× 203 0.6× 357 1.2× 95 0.6× 131 1.3× 33 979
Stephen P. Henry United States 10 572 1.3× 402 1.2× 187 0.6× 123 0.8× 40 0.4× 12 1.1k
Tamara Hermida‐Gómez Spain 19 397 0.9× 454 1.3× 228 0.8× 361 2.3× 64 0.6× 56 1.2k
Manon C. Zweers Netherlands 13 344 0.8× 219 0.6× 103 0.3× 155 1.0× 41 0.4× 16 1.1k
Cordula Surmann‐Schmitt Germany 13 390 0.9× 293 0.9× 121 0.4× 138 0.9× 34 0.3× 16 761

Countries citing papers authored by Xiaoyi Zhao

Since Specialization
Citations

This map shows the geographic impact of Xiaoyi Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyi Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyi Zhao more than expected).

Fields of papers citing papers by Xiaoyi Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyi Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyi Zhao. The network helps show where Xiaoyi Zhao may publish in the future.

Co-authorship network of co-authors of Xiaoyi Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyi Zhao. A scholar is included among the top collaborators of Xiaoyi Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyi Zhao. Xiaoyi Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Defeng, Chuanxu Liu, Yuhuan Liu, et al.. (2025). Discovery of novel and highly potent anticancer agents enabled by selenium scanning of noscapine. European Journal of Medicinal Chemistry. 293. 117714–117714.
2.
Long, Dianbo, Xiaoyi Zhao, Yiyang Xu, et al.. (2024). m7G-modified mt-tRF3b-LeuTAA regulates mitophagy and metabolic reprogramming via SUMOylation of SIRT3 in chondrocytes. Biomaterials. 314. 122903–122903. 12 indexed citations
3.
Wang, Pengfei, Peixuan Li, Qingqing Du, et al.. (2024). Sophoricoside reduces inflammation in type II collagen-induced arthritis by downregulating NLRP3 signaling. Biochemistry and Biophysics Reports. 40. 101867–101867. 3 indexed citations
5.
Zhao, Xiaoyi, Shady Younis, Hui Shi, et al.. (2022). RNA-seq characterization of histamine-releasing mast cells as potential therapeutic target of osteoarthritis. Clinical Immunology. 244. 109117–109117. 18 indexed citations
6.
Li, Hong‐Yi, Xiaoyi Zhao, Xingzhao Wen, et al.. (2020). Inhibition of miR-490-5p Promotes Human Adipose-Derived Stem Cells Chondrogenesis and Protects Chondrocytes via the PITPNM1/PI3K/AKT Axis. Frontiers in Cell and Developmental Biology. 8. 573221–573221. 20 indexed citations
7.
Zhao, Xiaoyi, Fangang Meng, Shu Hu, et al.. (2020). The Synovium Attenuates Cartilage Degeneration in KOA through Activation of the Smad2/3-Runx1 Cascade and Chondrogenesis-related miRNAs. Molecular Therapy — Nucleic Acids. 22. 832–845. 17 indexed citations
8.
Sun, Hao, Xingzhao Wen, Hongyi Li, et al.. (2019). Single-cell RNA-seq analysis identifies meniscus progenitors and reveals the progression of meniscus degeneration. Annals of the Rheumatic Diseases. 79(3). 408–417. 90 indexed citations
10.
Mao, Guping, Shu Hu, Ziji Zhang, et al.. (2018). Exosomal miR‐95‐5p regulates chondrogenesis and cartilage degradation via histone deacetylase 2/8. Journal of Cellular and Molecular Medicine. 22(11). 5354–5366. 100 indexed citations
11.
Sun, Hao, et al.. (2018). MiR-455-3p inhibits the degenerate process of chondrogenic differentiation through modification of DNA methylation. Cell Death and Disease. 9(5). 537–537. 32 indexed citations
12.
Meng, Fangang, Zhiwen Li, Zhiqi Zhang, et al.. (2018). MicroRNA-193b-3p regulates chondrogenesis and chondrocyte metabolism by targeting HDAC3. Theranostics. 8(10). 2862–2883. 123 indexed citations
13.
Wu, Peihui, Zhiqi Zhang, Minghui Gu, et al.. (2017). Radiographic Measurement of Femoral Lateral Bowing and Distal Femoral Condyle Resection Thickness. Chinese Medical Journal. 130(21). 2557–2562. 2 indexed citations
14.
Zhao, Xiaoyi, et al.. (2015). CCL3 serves as a potential plasma biomarker in knee degeneration (osteoarthritis). Osteoarthritis and Cartilage. 23(8). 1405–1411. 50 indexed citations
15.
Zhang, Ziji, Zhiqi Zhang, Peihui Wu, et al.. (2015). Presence and function of microRNA-92a in chondrogenic ATDC5 and adipose-derived mesenchymal stem cells. Molecular Medicine Reports. 12(4). 4877–4886. 27 indexed citations
16.
Kang, Yan, Ziji Zhang, Xiaoyi Zhao, et al.. (2012). Total hip arthroplasty for vascular necrosis of the femoral head in patients with systemic lupus erythematosus: a midterm follow-up study of 28 hips in 24 patients. European Journal of Orthopaedic Surgery & Traumatology. 23(1). 73–79. 19 indexed citations
17.
Zhang, Ziji, Yan Kang, Zhiqi Zhang, et al.. (2012). The influence of body mass index on life quality and clinical improvement after total hip arthroplasty. Journal of Orthopaedic Science. 17(3). 219–225. 15 indexed citations
18.
Santourlidis, Simeon, Peter Wernet, Foued Ghanjati, et al.. (2010). Unrestricted somatic stem cells (USSC) from human umbilical cord blood display uncommitted epigenetic signatures of the major stem cell pluripotency genes. Stem Cell Research. 6(1). 60–69. 29 indexed citations
19.
Liedtke, Stefanie, Anja Buchheiser, Frank Bosse, et al.. (2010). The HOX Code as a “biological fingerprint” to distinguish functionally distinct stem cell populations derived from cord blood. Stem Cell Research. 5(1). 40–50. 62 indexed citations
20.
Zhao, Xiaoyi, et al.. (2005). [Expressions of PDCD5 and p53 in oral leukoplakia and oral squamous cell carcinoma].. PubMed. 37(4). 429–32. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026